U.S. Markets open in 6 hrs 41 mins
S&P Futures
3,295.50+7.00(+0.21%)Dow Futures
26,647.00+89.00(+0.34%)Nasdaq Futures
11,076.00+31.75(+0.29%)
Novo Nordisk A/S (NOVC.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
56.29+0.74 (+1.33%)
At close: 5:35PM CEST
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 55.55 |
| Open | 55.33 |
| Bid | 55.76 x 13500 |
| Ask | 56.17 x 54600 |
| Day's Range | 54.81 - 56.29 |
| 52 Week Range | 42.74 - 61.13 |
| Volume | 15,223 |
| Avg. Volume | 14,890 |
| Market Cap | 142.77B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 26.56 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investopedia
10 Biggest Biotechnology Companies
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
- GuruFocus.com
Novo, Roche Scored Highest Returns on Invested Capital
During same 10-year period, Eisai and Abbott were worst performers in measure Continue reading...
- GlobeNewswire
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 20 July 2020 – On 11 May 2020, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European.
© 2020 Verizon Media. All rights reserved.
